Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis

(2014) S Meyfroidt et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis

(2013) Marije F. Bakker   ANNALS OF INTERNAL MEDICINE

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks

(2013) Debby den Uyl et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial

(2013) Kim Hørslev-Petersen et al.   ANNALS OF THE RHEUMATIC DISEASES

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review

(2013) Helga Radner et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Validation of the Methotrexate-First Strategy in Patients With Early, Poor-Prognosis Rheumatoid Arthritis: Results From a Two-Year Randomized, Double-Blind Trial

(2013) James R. O'Dell et al.   ARTHRITIS AND RHEUMATISM

Two-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice

(2013) D. De Cock et al.   CLINICAL RHEUMATOLOGY

Five-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort

(2013) B. Combe et al.   JOURNAL OF RHEUMATOLOGY

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

(2012) Marjatta Leirisalo-Repo et al.   ANNALS OF THE RHEUMATIC DISEASES

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

(2012) P H de Jong et al.   ANNALS OF THE RHEUMATIC DISEASES

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

(2012) Larry W. Moreland et al.   ARTHRITIS AND RHEUMATISM

Glucocorticoids

(2012) Cornelia M. Spies et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Optimal care for early RA patients: the challenge of translating scientific data into clinical practice

(2011) P. Verschueren et al.   RHEUMATOLOGY

Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

(2010) S. L. Gorter et al.   ANNALS OF THE RHEUMATIC DISEASES

Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons

(2010) Niels Graudal et al.   ARTHRITIS AND RHEUMATISM

Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis

(2010) Jos N. Hoes et al.   Nature Reviews Rheumatology

Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis

(2009) L. H. D. van Tuyl et al.   ANNALS OF THE RHEUMATIC DISEASES

DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis

(2009) Y P M Goekoop-Ruiterman et al.   ANNALS OF THE RHEUMATIC DISEASES

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

(2009) RF van Vollenhoven et al.   LANCET

A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis

(2009) Margaret H. Y. Ma et al.   RHEUMATOLOGY

Predictors of remission, normalized physical function, and changes in the working situation during follow‐up of patients with early rheumatoid arthritis: an observational study

(2009) P. Verschueren et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis

(2008) L. H. D. van Tuyl et al.   RHEUMATOLOGY

Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis

(2007) P. Verschueren et al.   RHEUMATOLOGY